Christopher J. Walkey

4.6k total citations · 2 hit papers
28 papers, 3.9k citations indexed

About

Christopher J. Walkey is a scholar working on Molecular Biology, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Christopher J. Walkey has authored 28 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Clinical Biochemistry. Recurrent topics in Christopher J. Walkey's work include Metabolism and Genetic Disorders (6 papers), Fungal and yeast genetics research (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Christopher J. Walkey is often cited by papers focused on Metabolism and Genetic Disorders (6 papers), Fungal and yeast genetics research (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Christopher J. Walkey collaborates with scholars based in Canada, United States and Egypt. Christopher J. Walkey's co-authors include Bruce M. Spiegelman, Pere Puigserver, Evan D. Rosen, Dennis E. Vance, Domenico Accili, John C. Yoon, Yukari Kitamura, H. Henry Dong, James Rhee and Francesco Oriente and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Christopher J. Walkey

28 papers receiving 3.8k citations

Hit Papers

Transcriptional regulation of adipogenesis 2000 2026 2008 2017 2000 2003 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Transcriptional regulation of adipogenesis
    2000 1.7k citations Evan D. Rosen, Christopher J. Walkey et al. Genes & Development profile →
  2. Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
    2003 1.2k citations Pere Puigserver, James Rhee et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher J. Walkey Canada 17 2.5k 1.3k 931 565 379 28 3.9k
Kimihiko Matsusue Japan 22 2.3k 0.9× 1.3k 0.9× 1.5k 1.6× 614 1.1× 635 1.7× 51 3.8k
Edwards A. Park United States 35 1.8k 0.7× 987 0.7× 587 0.6× 639 1.1× 397 1.0× 74 3.2k
Kiyoto Motojima Japan 27 2.0k 0.8× 1.0k 0.8× 654 0.7× 334 0.6× 513 1.4× 81 3.0k
Shanqin Xu United States 25 2.2k 0.9× 1.5k 1.1× 1.1k 1.1× 708 1.3× 400 1.1× 38 4.6k
Li Qiang United States 32 2.2k 0.9× 1.9k 1.4× 1.4k 1.5× 358 0.6× 270 0.7× 68 4.6k
Bingbing Jiang United States 29 2.6k 1.1× 1.4k 1.0× 1.1k 1.2× 705 1.2× 448 1.2× 42 4.9k
Stéphane Mandard France 21 2.2k 0.9× 1.3k 0.9× 929 1.0× 443 0.8× 370 1.0× 33 4.0k
Carina Prip‐Buus France 34 2.1k 0.9× 776 0.6× 520 0.6× 377 0.7× 286 0.8× 64 3.4k
Paul A. Grimaldi France 34 3.5k 1.4× 2.2k 1.7× 880 0.9× 504 0.9× 562 1.5× 63 4.9k
Harini Sampath United States 27 1.9k 0.8× 925 0.7× 776 0.8× 539 1.0× 637 1.7× 59 3.7k

Countries citing papers authored by Christopher J. Walkey

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Walkey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Walkey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Walkey more than expected).

Fields of papers citing papers by Christopher J. Walkey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Walkey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Walkey. The network helps show where Christopher J. Walkey may publish in the future.

Co-authorship network of co-authors of Christopher J. Walkey

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Walkey. A scholar is included among the top collaborators of Christopher J. Walkey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Walkey. Christopher J. Walkey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Qin, Albert T. Chen, Ken Y. Chan, et al.. (2023). Targeting AAV vectors to the central nervous system by engineering capsid–receptor interactions that enable crossing of the blood–brain barrier. PLoS Biology. 21(7). e3002112–e3002112. 43 indexed citations
2.
Lőrincz, Réka, Christopher J. Walkey, Samir Andrade Mendonça, et al.. (2022). In vivo editing of the pan-endothelium by immunity evading simian adenoviral vector. Biomedicine & Pharmacotherapy. 158. 114189–114189. 7 indexed citations
3.
Ahmad, Naseer, Li Sun, James Iben, et al.. (2022). MAF1, a repressor of RNA polymerase III-dependent transcription, regulates bone mass. eLife. 11. 9 indexed citations
4.
Liang, Shun‐Qing, Christopher J. Walkey, Qin Su, et al.. (2021). AAV5 delivery of CRISPR-Cas9 supports effective genome editing in mouse lung airway. Molecular Therapy. 30(1). 238–243. 31 indexed citations
5.
Rusin, Aleksandra, et al.. (2019). The RNA polymerase III repressor MAF1 is regulated by ubiquitin-dependent proteasome degradation and modulates cancer drug resistance and apoptosis. Journal of Biological Chemistry. 294(50). 19255–19268. 9 indexed citations
6.
Lanz, Rainer B., et al.. (2018). Maf1 and Repression of RNA Polymerase III-Mediated Transcription Drive Adipocyte Differentiation. Cell Reports. 24(7). 1852–1864. 25 indexed citations
7.
Liu, Yazheng, Christopher J. Walkey, Tim Green, Hennie J.J. van Vuuren, & David D. Kitts. (2015). Enhancing the natural folate level in wine using bioengineering and stabilization strategies. Food Chemistry. 194. 26–31. 11 indexed citations
8.
Bessonov, Kyrylo, Christopher J. Walkey, Barry J. Shelp, et al.. (2013). Functional Analyses of NSF1 in Wine Yeast Using Interconnected Correlation Clustering and Molecular Analyses. PLoS ONE. 8(10). e77192–e77192. 5 indexed citations
9.
Walkey, Christopher J., Zongli Luo, Lufiani L. Madilao, & Hennie J.J. van Vuuren. (2012). The Fermentation Stress Response Protein Aaf1p/Yml081Wp Regulates Acetate Production in Saccharomyces cerevisiae. PLoS ONE. 7(12). e51551–e51551. 21 indexed citations
10.
Walkey, Christopher J., Zongli Luo, Christoph H. Borchers, Vivien Measday, & Hennie J.J. van Vuuren. (2011). The Saccharomyces cerevisiae fermentation stress response protein Igd1p/Yfr017p regulates glycogen levels by inhibiting the glycogen debranching enzyme. FEMS Yeast Research. 11(6). 499–508. 6 indexed citations
11.
Walkey, Christopher J. & Bruce M. Spiegelman. (2008). A Functional Peroxisome Proliferator-activated Receptor-γ Ligand-binding Domain Is Not Required for Adipogenesis. Journal of Biological Chemistry. 283(36). 24290–24294. 41 indexed citations
12.
Puigserver, Pere, James Rhee, Christopher J. Walkey, et al.. (2003). Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction. Nature. 423(6939). 550–555. 1216 indexed citations breakdown →
13.
Rosen, Evan D., Christopher J. Walkey, Pere Puigserver, & Bruce M. Spiegelman. (2000). Transcriptional regulation of adipogenesis. Genes & Development. 14(11). 1293–1307. 1657 indexed citations breakdown →
14.
Walkey, Christopher J., David J. Shields, & Dennis E. Vance. (1999). Identification of three novel cDNAs for human phosphatidylethanolamine N-methyltransferase and localization of the human gene on chromosome 17p11.2. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1436(3). 405–412. 20 indexed citations
15.
Agellon, Luis B., Christopher J. Walkey, Dennis E. Vance, Folkert Kuipers, & Henkjan J. Verkade. (1999). The unique acyl chain specificity of biliary phosphatidylcholines in mice is independent of their biosynthetic origin in the liver. Hepatology. 30(3). 725–729. 25 indexed citations
16.
Vance, Dennis E. & Christopher J. Walkey. (1998). Roles for the methylation of phosphatidylethanolamine. Current Opinion in Lipidology. 9(2). 125–130. 13 indexed citations
17.
Walkey, Christopher J., Liqing Yu, Luis B. Agellon, & Dennis E. Vance. (1998). Biochemical and Evolutionary Significance of Phospholipid Methylation. Journal of Biological Chemistry. 273(42). 27043–27046. 189 indexed citations
18.
Vance, Dennis E., Christopher J. Walkey, & Zheng Cui. (1997). Phosphatidylethanolamine N-methyltransferase from liver. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1348(1-2). 142–150. 179 indexed citations
19.
Walkey, Christopher J., et al.. (1997). Disruption of the murine gene encoding phosphatidylethanolamine  N -methyltransferase. Proceedings of the National Academy of Sciences. 94(24). 12880–12885. 137 indexed citations
20.
Johnson, Joanne E., Gabriel B. Kalmar, Parmjit Sohal, et al.. (1992). Comparison of the lipid regulation of yeast and rat CTP: phosphocholine cytidylyltransferase expressed in COS cells. Biochemical Journal. 285(3). 815–820. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimihiko Matsusue Breakdown of academic impact, for papers by Edwards A. Park Breakdown of academic impact, for papers by Kiyoto Motojima Breakdown of academic impact, for papers by Shanqin Xu Breakdown of academic impact, for papers by Li Qiang Breakdown of academic impact, for papers by Bingbing Jiang Breakdown of academic impact, for papers by Stéphane Mandard Breakdown of academic impact, for papers by Carina Prip‐Buus Breakdown of academic impact, for papers by Paul A. Grimaldi Breakdown of academic impact, for papers by Harini Sampath
Rankless by CCL
2026